Form 4: Cardinal Health Insider Sells Shares, Gains RSUs

Cardinal Health's Chief Accounting Officer reported the sale of common shares and the acquisition of restricted share units.

Summary

• Mary C. Scherer, Chief Accounting Officer of Cardinal Health Inc. (CAH), reported changes in her beneficial ownership of common shares.
• On August 15, 2025, 1,203 common shares were acquired through a grant of restricted share units (RSUs) at a price of $0, which will vest in three equal annual installments beginning August 15, 2026.
• Also on August 15, 2025, 2,572 common shares were disposed of at $150.22 to satisfy tax withholding obligations related to the vesting of 2,880 RSUs and 3,029 performance share units.
• On August 19, 2025, 6,766 common shares were sold at a weighted average price of $149.25, with prices ranging from $148.94 to $149.60.
• Following these transactions, direct beneficial ownership stands at 3,556 common shares.

Sentiment

Score: 5

Explanation: The filing details routine insider transactions, including both the grant of restricted share units and the sale of common shares, which balances the overall sentiment. It does not indicate significant positive or negative company performance.

Positives

• The grant of 1,203 restricted share units at no cost aligns management's interests with long-term shareholder value through future equity ownership.

Negatives

• The sale of 6,766 common shares by a key executive could be perceived as a reduction in insider confidence, although it is a relatively small amount.
• The disposition of 2,572 shares for tax withholding purposes reduces the executive's direct ownership.

Risks

• Insider selling, even for personal financial planning or tax obligations, can sometimes be interpreted negatively by the market, potentially influencing investor sentiment.

Future Outlook

The granted restricted share units are scheduled to begin vesting in three equal annual installments starting August 15, 2026, indicating future equity compensation for the Chief Accounting Officer.

Industry Context

This filing is a routine insider transaction report and does not provide information related to broader industry trends or competitive landscape within the healthcare services and products sector.

Stakeholder Impact

• Shareholders will note the Chief Accounting Officer's stock transactions, which include both the acquisition of future equity through RSUs and the sale of existing shares.

Next Steps

• The granted restricted share units will begin vesting in three equal annual installments starting August 15, 2026.

Key Dates

Keywords

Cardinal Health, CAH, Form 4, insider trading, stock sale, RSU, restricted share units, Mary C. Scherer, Chief Accounting Officer